Literature DB >> 20099363

Measurement of brain iron distribution in Hallevorden-Spatz syndrome.

Jerzy Szumowski1, Erhan Bas, Kirsten Gaarder, Erwin Schwarz, Deniz Erdogmus, Susan Hayflick.   

Abstract

PURPOSE: To investigate spatial distribution of iron accumulation in the globus pallidus (GP) in patients with Hallevorden-Spatz syndrome (HSS) using phase imaging. We compared sensitivity of a phase imaging technique to relaxation rate measurement methods (R1,R2,R2*) for iron quantification.
MATERIALS AND METHODS: R1, R2, and R2* were measured in GP structure of the brain of eight pantothenate kinase-associated neurodegeneration (PKAN) patients and a healthy volunteer using a 3T magnetic resonance imaging (MRI) scanner. The phase of gradient-echo images was preprocessed to eliminate phase 2pi wrapping and filtered to remove phase background variations. Phase gap across GP structure was used as a metric for iron effects quantification.
RESULTS: Among the relaxation rates the most sensitive to iron accumulation was the R2* rate. The R1 and R2 rates demonstrated only small variations in this group of subjects. Up to an order of magnitude phase gap changes were measured between one PKAN patient and an age-matched healthy volunteer. Assuming that phase gap differences scale linearly with iron concentration we estimate that up to 2 mg Fe/g ww accumulates in GP of these patients.
CONCLUSION: Our results demonstrate significantly higher sensitivity of the phase measurements for quantitative assessment of iron concentration compared to the relaxation rate measurements. Phase measurements could potentially be used for monitoring a progression and a response to therapy in PKAN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20099363     DOI: 10.1002/jmri.22031

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  10 in total

1.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

2.  Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population.

Authors:  Susanne A Schneider; Giovanna Zorzi; Nardo Nardocci
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

3.  Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* time.

Authors:  R Fermin-Delgado; P Roa-Sanchez; H Speckter; E Perez-Then; D Rivera-Mejia; B Foerster; P Stoeter
Journal:  Clin Neuroradiol       Date:  2012-01-19       Impact factor: 3.649

4.  Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase-Associated Neurodegeneration.

Authors:  J-H Lee; A Gregory; P Hogarth; C Rogers; S J Hayflick
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

Review 5.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

6.  Progressive brain iron accumulation in neuroferritinopathy measured by the thalamic T2* relaxation rate.

Authors:  A McNeill; G Gorman; A Khan; R Horvath; A M Blamire; P F Chinnery
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

7.  Voxel-based analysis in neuroferritinopathy expands the phenotype and determines radiological correlates of disease severity.

Authors:  M J Keogh; B S Aribisala; J He; E Tulip; D Butteriss; C Morris; G Gorman; R Horvath; P F Chinnery; Andrew M Blamire
Journal:  J Neurol       Date:  2015-07-04       Impact factor: 4.849

8.  Transverse Relaxation Rate of Cyst Fluid Can Predict Malignant Transformation of Ovarian Endometriosis.

Authors:  Chiharu Yoshimoto; Junko Takahama; Takuya Iwabuchi; Masato Uchikoshi; Hiroshi Shigetomi; Hiroshi Kobayashi
Journal:  Magn Reson Med Sci       Date:  2016-09-16       Impact factor: 2.471

Review 9.  The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.

Authors:  George J Kontoghiorghes; Marios Kleanthous; Christina N Kontoghiorghe
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-01-01       Impact factor: 2.576

10.  Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).

Authors:  Susanne A Schneider; Petr Dusek; John Hardy; Ana Westenberger; Joseph Jankovic; Kailash P Bhatia
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.